(Q51716894)

10 April 2018

editorial

0 references

title

Calling for rapid development of a safe and effective MERS vaccine. (English)

1 reference

10 April 2018

author

Peter J. Hotez

1

1 reference

10 April 2018

Sara Lustigman

5

object named as

Sara Lustigman

1 reference

10 April 2018

2

Maria Elena Bottazzi

1 reference

10 April 2018

7

Shibo Jiang

1 reference

10 April 2018

Lanying Du

6

object named as

Lanying Du

1 reference

10 April 2018

Bin Zhan

4

object named as

Bin Zhan

1 reference

10 April 2018

author name string

Chien-Te K Tseng

3

1 reference

10 April 2018

publication date

12 June 2014

1 reference

10 April 2018

published in

Microbes and Infection

1 reference

10 April 2018

volume

16

1 reference

10 April 2018

issue

7

1 reference

10 April 2018

page(s)

529-531

1 reference

10 April 2018

In search of a vaccine for respiratory syncytial virus: the saga continues

cites work

1 reference

12 December 2020

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines

1 reference

12 December 2020

The spike protein of SARS-CoV--a target for vaccine and therapeutic development

1 reference

12 December 2020

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development

1 reference

12 December 2020

Current advancements and potential strategies in the development of MERS-CoV vaccines

1 reference

12 December 2020

Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway

1 reference

12 December 2020

Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus

1 reference

12 December 2020

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

12 December 2020

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

1 reference

12 December 2020

Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome

1 reference

12 December 2020

10.1016/J.MICINF.2014.05.002

Identifiers

DOI

1 reference

10 April 2018

PubMed ID

24931059

1 reference

10 April 2018